Raymond James Financial Services Advisors’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$27.4K	Sell	10,552 -1,183	-10%	-$3.08K	﹤0.01%	3360
2024 Q2	$34.7K	Buy	11,735 +300	+3%	+$888	﹤0.01%	3308
2024 Q1	$51.8K	Buy	11,435 +500	+5%	+$2.27K	﹤0.01%	3284
2023 Q4	$62.4K	Buy	+10,935	New	+$62.4K	﹤0.01%	3169